JBF Capital’s Epizyme, Inc EPZM Stock Holding History

JBF Capital’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-260,000	Closed	-$382K	–	87
2022 Q2	$382K	Buy	+260,000	New	+$191K	0.09%	39

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

JBF Capital's EPZM Position: Q3 2022 in Review

JBF Capital sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 260,000 shares — an estimated $382K sold.

JBF Capital first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $382K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

JBF Capital reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
JBF Capital sold 260,000 Epizyme, Inc shares in Q3 2022, an estimated $382K.
JBF Capital first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
JBF Capital's Epizyme, Inc position peaked at $382K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on JBF Capital's 13F filing for Q3 2022, filed 9 Nov 2022.